表紙
市場調查報告書
商品編碼
962808

遺傳基因編輯的全球市場 (2020-2026年):市場預測 (各用途、技術、終端用戶)、產業分析、地區的展望、潛在性、價格趨勢、市場佔有率

Gene Editing Market Size By Application, By Technology, By End-user, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

出版日期: | 出版商: Global Market Insights Inc. | 英文 141 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球遺傳基因編輯的市場,由於遺傳性疾病的發病率上升,先進的遺傳基因編輯技術的持續開發,CRISPR技術的高引進率等要素,預計今後數年顯示大幅度的成長。各用途中,由於廣泛的用途,細胞株工程的部門在期間中將以超過14.5%的年複合成長率成長。還有各技術中,CRISPR/Cas9部門在2019年顯示約46.5%的市場佔有率,預計今後數年也穩定成長。

本報告提供全球遺傳基因編輯的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,用途、技術、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 調查手法、調查範圍

第2章 摘要整理

第3章 產業考察

  • 產業區分
  • 產業的變化、展望
  • 產業影響要素
    • 成長要素
    • 課題
  • 成長的潛在性分析
  • COVID-19的影響
  • 競爭環境
  • 波特分析
  • PESTEL分析

第4章 市場分析、預測:各用途

  • 主要趨勢
  • 細胞株工程
  • 動物基因工程學
  • 植物基因工程學
  • 其他

第5章 市場分析、預測:各技術

  • 主要趨勢
  • CRISPR/Cas9
  • ZFN
  • TALEN
  • 其他

第6章 市場分析、預測:各終端用戶

  • 主要趨勢
  • 生物科技、製藥企業
  • CRO
  • 研究機關

第7章 市場分析、預測:各地區、主要國家

  • 主要趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 中南美
  • 中東、非洲

第8章 企業簡介

  • Addgene, Inc.
  • Agilent Technologies, Inc.
  • Allele Biotechnology and Pharmaceuticals Inc.
  • Applied StemCell
  • ATUM (DNA 2.0)
  • Bio-Rad Laboratories
  • Caribou Biosciences, Inc.
  • CRISPR Therapeutics
  • EMD Millipore (Merck KGaA)
  • GeneCopoeia
  • GenScript Corporation
  • Horizon Discovery Ltd
  • Integrated DNA Technologies Inc.
  • Origene Technologies
  • Precision Biosciences
  • Sangamo Therapeutics
  • Takara Bio Inc.
  • Thermo Fisher Scientific
  • Beam Therapeutics
  • Bluebird bio, Inc.
  • Editas Medicine
  • Intellia Therapeutics
目錄
Product Code: 810

Title:
Gene Editing Market Size By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENs), By End-user (Biotech and Pharma Companies, Contract Research Organizations (CROs), Research Institutes), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026.

Gene editing market is likely to record substantial growth in coming years owing to rising incidences of genetic disorders, ongoing development of advanced gene editing technologies, and high adoption of CRISPR technology.

Gene editing or genome editing is group of technologies that gives scientist the capability to change DNA of an organism, including animals, bacteria, and plants. Editing DNA could further lead to changes in physical traits such as disease risk, and eye color. Scientist generally utilize different technologies to do this. These technologies, further allow the genetic material to be altered, removed or added at a specific place in the genome.

The gene editing market is bifurcated in terms of application, technology, end-user, and regional landscape.

With respect to application, the gene editing market is classified into plant genetic engineering, animal genetic engineering, cell line engineering, and others. Among these, cell line engineering segment will witness more than 14.5% CAGR over the forecast time period. Extensive applications of cell line engineering are likely to augment the segment growth.

The current technology in gene editing nucleases such as TALENs (transcription activator-like effector nucleases), ZFNs (zinc finger nucleases), and CRISPR/Cas systems have further made cell engineering relatively cheaper and easy fostering revenue outlook.

Based on technology, the gene editing market is categorized into TALENs, ZFNs, CRISPR/Cas9, and others. In 2019, the CRISPR/Cas9 segment held around 46.5% market share with estimates expecting it to follow a lucrative growth trend over the coming years. The growth is ascribed to rising preference towards CRISPR technology owing to several segmental advantages.

CRISPR-Cas9 is one of the most efficient and inexpensive system used for genome editing. The functions of CRISPR along with other related genes is important in adaptive immunity in selective archaea and bacteria. It further enables organism to respond to and remove any invading genetic material.

In terms of end-user, the overall gene editing market is segmented into research institutes, contract research organizations (CROs), and biotech & pharma companies. Among these, biotech & pharma companies segment is slated to witness remarkable growth over the coming years. In 2019, the segment accounted for a market valuation of more than $1.5 billion. The growth is ascribed to the increasing focus of biopharmaceutical companies on developing advanced gene editing technologies.

From a regional frame of reference, Latin America gene editing market will witness substantial growth over the coming years. The region in 2019, accounted for over 11% market share, attributable to rising incidences of genetic disorders across several Latin American countries.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Base estimates & working
  • 1.3. Forecast calculations
  • 1.4. Data validation
  • 1.5. Data sources
    • 1.5.1. Secondary
      • 1.5.1.1. Paid sources
      • 1.5.1.2. Unpaid sources
    • 1.5.2. Primary

Chapter 2. Executive Summary

  • 2.1. Gene editing industry 360 degree synopsis, 2015 - 2026
    • 2.1.1. Business trends
    • 2.1.2. Application trends
    • 2.1.3. Technology trends
    • 2.1.4. End-user trends
    • 2.1.5. Regional trends

Chapter 3. Gene Editing Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2015 - 2026
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increased funding for genetic research in North America
      • 3.3.1.2. Rising R&D expenditure and growth of biotechnology in Europe
      • 3.3.1.3. Increasing demand for synthetic genes in Asia Pacific and North America
      • 3.3.1.4. Technology advancements in gene editing in North America
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. Stringent government regulations
      • 3.3.2.2. Lack of public awareness in underdeveloped economies
  • 3.4. Growth potential analysis
    • 3.4.1. By application
    • 3.4.2. By technology
    • 3.4.3. By end-user
  • 3.5. COVID-19 impact analysis
  • 3.6. Competitive landscape, 2019
    • 3.6.1. Strategy dashboard, 2019
  • 3.7. Porter's analysis
  • 3.8. PESTEL analysis

Chapter 4. Gene Editing Market, By Application

  • 4.1. Key segment trends
  • 4.2. Cell line engineering
    • 4.2.1. Market size, by region, 2015-2026 (USD Million)
  • 4.3. Animal genetic engineering
    • 4.3.1. Market size, by region, 2015-2026 (USD Million)
  • 4.4. Plant genetic engineering
    • 4.4.1. Market size, by region, 2015-2026 (USD Million)
  • 4.5. Others
    • 4.5.1. Market size, by region, 2015-2026 (USD Million)

Chapter 5. Gene Editing Market, By Technology

  • 5.1. Key segment trends
  • 5.2. CRISPR/Cas9
    • 5.2.1. Market size, by region, 2015-2026 (USD Million)
  • 5.3. Zinc Finger Nucleases (ZFNs)
    • 5.3.1. Market size, by region, 2015-2026 (USD Million)
  • 5.4. TALENs
    • 5.4.1. Market size, by region, 2015-2026 (USD Million)
  • 5.5. Others
    • 5.5.1. Market size, by region, 2015-2026 (USD Million)

Chapter 6. Gene Editing Market, By End-user

  • 6.1. Key segment trends
  • 6.2. Biotech and pharma companies
    • 6.2.1. Market size, by region, 2015-2026 (USD Million)
  • 6.3. Contract research organizations (CROs)
    • 6.3.1. Market size, by region, 2015-2026 (USD Million)
  • 6.4. Research institutes
    • 6.4.1. Market size, by region, 2015-2026 (USD Million)

Chapter 7. Gene Editing Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2015-2026 (USD Million)
    • 7.2.2. Market size, by application, 2015-2026 (USD Million)
    • 7.2.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.2.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.2.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.2.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.2.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.2.6.3. Market size, by end-user, 2015-2026 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2015-2026 (USD Million)
    • 7.3.2. Market size, by application, 2015-2026 (USD Million)
    • 7.3.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.3.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.6.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.7.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.7.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.8.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.8.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.9.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.9.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.10. Russia
      • 7.3.10.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.10.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.10.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.3.11. Poland
      • 7.3.11.1. Market size, by application, 2015-2026 (USD Million)
      • 7.3.11.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.3.11.3. Market size, by end-user, 2015-2026 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2015-2026 (USD Million)
    • 7.4.2. Market size, by application, 2015-2026 (USD Million)
    • 7.4.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.4.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.6. China
      • 7.4.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.6.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.7.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.7.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.8. Australia
      • 7.4.8.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.8.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.8.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.4.9. South Korea
      • 7.4.9.1. Market size, by application, 2015-2026 (USD Million)
      • 7.4.9.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.4.9.3. Market size, by end-user, 2015-2026 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2015-2026 (USD Million)
    • 7.5.2. Market size, by application, 2015-2026 (USD Million)
    • 7.5.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.5.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.5.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.5.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.5.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.5.6.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size, by application, 2015-2026 (USD Million)
      • 7.5.7.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.5.7.3. Market size, by end-user, 2015-2026 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Market size, by country, 2015-2026 (USD Million)
    • 7.6.2. Market size, by application, 2015-2026 (USD Million)
    • 7.6.3. Market size, by technology, 2015-2026 (USD Million)
    • 7.6.4. Market size, by end-user, 2015-2026 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by application, 2015-2026 (USD Million)
      • 7.6.5.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.6.5.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by application, 2015-2026 (USD Million)
      • 7.6.6.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.6.6.3. Market size, by end-user, 2015-2026 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size, by application, 2015-2026 (USD Million)
      • 7.6.7.2. Market size, by technology, 2015-2026 (USD Million)
      • 7.6.7.3. Market size, by end-user, 2015-2026 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Addgene, Inc.
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Agilent Technologies, Inc.
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Allele Biotechnology and Pharmaceuticals Inc.
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Applied StemCell
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. ATUM (DNA 2.0)
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Bio-Rad Laboratories
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Caribou Biosciences, Inc.
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. CRISPR Therapeutics
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. EMD Millipore (Merck KGaA)
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. GeneCopoeia
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. GenScript Corporation
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Horizon Discovery Ltd
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Integrated DNA Technologies Inc.
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
  • 8.14. Origene Technologies
    • 8.14.1. Business overview
    • 8.14.2. Financial data
    • 8.14.3. Product landscape
    • 8.14.4. Strategic outlook
    • 8.14.5. SWOT analysis
  • 8.15. Precision Biosciences
    • 8.15.1. Business overview
    • 8.15.2. Financial data
    • 8.15.3. Product landscape
    • 8.15.4. Strategic outlook
    • 8.15.5. SWOT analysis
  • 8.16. Sangamo Therapeutics
    • 8.16.1. Business overview
    • 8.16.2. Financial data
    • 8.16.3. Product landscape
    • 8.16.4. Strategic outlook
    • 8.16.5. SWOT analysis
  • 8.17. Takara Bio Inc.
    • 8.17.1. Business overview
    • 8.17.2. Financial data
    • 8.17.3. Product landscape
    • 8.17.4. Strategic outlook
    • 8.17.5. SWOT analysis
  • 8.18. Thermo Fisher Scientific
    • 8.18.1. Business overview
    • 8.18.2. Financial data
    • 8.18.3. Product landscape
    • 8.18.4. Strategic outlook
    • 8.18.5. SWOT analysis
  • 8.19. Beam Therapeutics
    • 8.19.1. Business overview
    • 8.19.2. Financial data
    • 8.19.3. Product landscape
    • 8.19.4. Strategic outlook
    • 8.19.5. SWOT analysis
  • 8.20. Bluebird bio, Inc.
    • 8.20.1. Business overview
    • 8.20.2. Financial data
    • 8.20.3. Product landscape
    • 8.20.4. Strategic outlook
    • 8.20.5. SWOT analysis
  • 8.21. Editas Medicine
    • 8.21.1. Business overview
    • 8.21.2. Financial data
    • 8.21.3. Product landscape
    • 8.21.4. Strategic outlook
    • 8.21.5. SWOT analysis
  • 8.22. Intellia Therapeutics
    • 8.22.1. Business overview
    • 8.22.2. Financial data
    • 8.22.3. Product landscape
    • 8.22.4. Strategic outlook
    • 8.22.5. SWOT analysis

Data Tables

  • TABLE 1 Gene editing industry 360 degree synopsis, 2015 - 2026
  • TABLE 2 Global gene editing market size, 2015 - 2019 (USD Million)
  • TABLE 3 Global gene editing market size, 2020 - 2026 (USD Million)
  • TABLE 4 Gene editing market size, by application, 2015 - 2019 (USD Million)
  • TABLE 5 Gene editing market size, by application, 2020 - 2026 (USD Million)
  • TABLE 6 Gene editing market size, by technology, 2015 - 2019 (USD Million)
  • TABLE 7 Gene editing market size, by technology, 2020 - 2026 (USD Million)
  • TABLE 8 Gene editing market size, by end-user, 2015 - 2019 (USD Million)
  • TABLE 9 Gene editing market size, by end-user, 2020 - 2026 (USD Million)
  • TABLE 10 Gene editing market size, by region, 2015 - 2019 (USD Million)
  • TABLE 11 Gene editing market size, by region, 2020 - 2026 (USD Million)
  • TABLE 12 Industry impact forces
  • TABLE 13 Cell line engineering market size, by region, 2015 - 2026 (USD Million)
  • TABLE 14 Animal genetic engineering market size, by region, 2015 - 2026 (USD Million)
  • TABLE 15 Plant genetic engineering market size, by region, 2015 - 2026 (USD Million)
  • TABLE 16 Others market size, by region, 2015 - 2026 (USD Million)
  • TABLE 17 CRISPR/Cas9 market size, by region, 2015 - 2026 (USD Million)
  • TABLE 18 Zinc Finger Nucleases (ZFNs) market size, by region, 2015 - 2026 (USD Million)
  • TABLE 19 TALENs market size, by region, 2015 - 2026 (USD Million)
  • TABLE 20 Others market size, by region, 2015 - 2026 (USD Million)
  • TABLE 21 Biotech and pharma companies market size, by region, 2015 - 2026 (USD Million)
  • TABLE 22 Contract research organizations (CROs) market size, by region, 2015 - 2026 (USD Million)
  • TABLE 23 Research institutes market size, by region, 2015 - 2026 (USD Million)
  • TABLE 24 North America gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 25 North America gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 26 North America gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 27 North America gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 28 U.S. gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 29 U.S. gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 30 U.S. gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 31 Canada gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 32 Canada gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 33 Canada gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 34 Europe gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 35 Europe gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 36 Europe gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 37 Europe gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 38 UK gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 39 UK gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 40 UK gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 41 Germany gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 42 Germany gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 43 Germany gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 44 France gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 45 France gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 46 France gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 47 Spain gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 48 Spain gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 49 Spain gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 50 Russia gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 51 Russia gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 52 Russia gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 53 Italy gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 54 Italy gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 55 Italy gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 56 Poland gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 57 Poland gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 58 Poland gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 59 Asia Pacific gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 60 Asia Pacific gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 61 Asia Pacific gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 62 Asia Pacific gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 63 China gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 64 China gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 65 China gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 66 Japan gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 67 Japan gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 68 Japan gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 69 India gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 70 India gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 71 India gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 72 Australia gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 73 Australia gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 74 Australia gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 75 South Korea gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 76 South Korea gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 77 South Korea gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 78 Latin America gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 79 Latin America gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 80 Latin America gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 81 Latin America gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 82 Argentina gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 83 Argentina gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 84 Argentina gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 85 Brazil gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 86 Brazil gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 87 Brazil gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 88 Mexico gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 89 Mexico gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 90 Mexico gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 91 MEA gene editing market size, by country, 2015 - 2026 (USD Million)
  • TABLE 92 MEA gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 93 MEA gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 94 MEA gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 95 South Africa gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 96 South Africa gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 97 South Africa gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 98 Saudi Arabia gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 99 Saudi Arabia gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 100 Saudi Arabia gene editing market size, by end-user, 2015 - 2026 (USD Million)
  • TABLE 101 UAE gene editing market size, by application, 2015 - 2026 (USD Million)
  • TABLE 102 UAE gene editing market size, by technology, 2015 - 2026 (USD Million)
  • TABLE 103 UAE gene editing market size, by end-user, 2015 - 2026 (USD Million)

Charts & Figures

  • FIG. 1 Market estimation and forecast methodology
  • FIG. 2 Gene editing industry 36 degree synopsis
  • FIG. 3 Industry segmentation
  • FIG. 4 Global gene editing market size, 2015 - 2026 (USD Million)
  • FIG. 5 Growth potential analysis, by application
  • FIG. 6 Growth potential analysis, by technology
  • FIG. 7 Growth potential analysis, by end-user
  • FIG. 8 Strategy dashboard
  • FIG. 9 Porter's analysis
  • FIG. 10 PESTLE analysis
  • FIG. 11 Key segment trends, by application
  • FIG. 12 Key segment trends, by technology
  • FIG. 13 Key segment trends, by end-user
  • FIG. 14 Key segment trends, by region